The evolutionary history of metastatic pancreatic neuroendocrine tumors reveals a therapy driven route to high-grade transformation

被引：0

作者：

Backman, S. ^{[1
]}

Botling, J. ^{[2
,3
]}

Nord, H. ^{[4
]}

Ghosal, S. ^{[5
]}

Stalberg, P. ^{[1
]}

Juhlin, C. C. ^{[6
]}

Hellman, P. ^{[1
]}

Skogseid, B. ^{[7
]}

Pacak, K. ^{[5
]}

Mollazadegan, K. ^{[7
]}

Akerstrom, T. ^{[1
]}

Crona, J. ^{[7
]}

机构：

[1] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden

[2] Uppsala Univ, Uppsala, Sweden

[3] Univ Gothenburg, Gothenburg, Sweden

[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden

[5] NIH, Sect Med Neuroendocrinol, Bethesda, MD USA

[6] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[7] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

来源：

关键词：

pancreatic neuroendocrine tumor; tumor evolution; alkylating chemotherapy; treatment resistance;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A03

引用

页码：20 / 20

页数：1